You can buy or sell KemPharm and other stocks, options, and ETFs commission-free!
KemPharm, Inc. Common Stock, also called KemPharm, is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA. The listed name for KMPH is KemPharm, Inc. Common Stock.
Travis C. Mickle
52 Week High
52 Week Low
Mid-Day Market Update: Crude Oil Surges 3%; KemPharm Shares Spike Higher
Midway through trading Wednesday, the Dow traded up 0.26% to 31,472 while the NASDAQ fell 1.02% to 13,222.06. The S&P also fell, dropping 0.30% to 3,858.49. Th
Why Is It Moving? Analyzing The Upward Movement in KemPharm's Stock Today
The Price And Volume Action In KemPharm's Stock Today KemPharm's (NASDAQ:KMPH) stock is trading up 46.23% to a price of $14.92. Wednesday the stock has been tr
— per share
Expected Nov 12, After Hours